LCD/NCD Portal

NCD150.7

 

PROLOTHERAPY, JOINT SCLEROTHERAPY, AND LIGAMENTOUS INJECTIONS WITH SCLEROSING AGENTS

 

Effective Date of this Version

• 9/27/1999

 

Benefit Category

• Physicians' Services.

• Note: This may not be an exhaustive list of all applicable Medicare benefit categories for this item or service.

 

Indications and Limitations of Coverage

• The medical effectiveness of the above therapies has not been verified by scientifically controlled studies.

• Accordingly, reimbursement for these modalities should be denied on the ground that they are NOT reasonable and necessary as required by §1862(a)(1) of the Act.

 

National Coverage Analyses (NCAs)

• This NCD has been or is currently being reviewed under the National Coverage Determination process.

o The following are existing associations with NCAs, from the National Coverage Analyses database.

o Original consideration for Prolotherapy for Chronic Low Back Pain (CAG-00045N) opens in new window

 

Medicare NCD Link